0000899243-20-035210.txt : 20201228
0000899243-20-035210.hdr.sgml : 20201228
20201228165010
ACCESSION NUMBER: 0000899243-20-035210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201222
FILED AS OF DATE: 20201228
DATE AS OF CHANGE: 20201228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pandite Arundathy N.
CENTRAL INDEX KEY: 0001827232
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39593
FILM NUMBER: 201418910
MAIL ADDRESS:
STREET 1: 1018 W 11TH ST., SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shattuck Labs, Inc.
CENTRAL INDEX KEY: 0001680367
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 812575858
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1018 W. 11TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78703
BUSINESS PHONE: 919-864-2700
MAIL ADDRESS:
STREET 1: 1018 W. 11TH STREET
CITY: AUSTIN
STATE: TX
ZIP: 78703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-22
0
0001680367
Shattuck Labs, Inc.
STTK
0001827232
Pandite Arundathy N.
C/O SHATTUCK LABS, INC.
1018 W. 11TH STREET, SUITE 100
AUSTIN
TX
78703
0
1
0
0
Chief Medical Officer
Stock Option (Right to Buy)
53.02
2020-12-22
4
A
0
27563
0.00
A
2030-12-22
Common Stock
27563
27563
D
This option represents a right to purchase a total of 27,563 shares of the Issuer's common stock, one quarter of which will vest on December 22, 2021, with the remaining three quarters vesting in equal monthly installments through December 22, 2024, subject to the Reporting Person's continued service to the Issuer.
/s/ Erin Ator Thomson, Attorney-in-fact for Arundathy N. Pandite
2020-12-28